In this article

A useful Amble review should explain what happens after the initial advertisement: who qualifies, how ongoing care is arranged, and which practical questions still need an answer. This guide brings the relevant company policies together with medical context.

We checked the accessible primary sources on September 23, 2026 and identify dated or unavailable documents where relevant. Provider statements are attributed, unresolved details remain explicit, and none of these answers is a personal prescribing decision. Use the linked original policy when confirming the terms for your own plan.

THE SHORT ANSWER

Amble’s public semaglutide safety information describes BMI 30 or greater, or 27 or greater with at least one weight-related condition. Its weight-loss FAQ says a licensed provider reviews health history, goals, and current medications before deciding whether to prescribe.

What to know first

  • Amble’s public semaglutide safety information describes BMI 30 or greater, or 27 or greater with at least one weight-related condition. Its weight-loss FAQ says a licensed provider reviews health history, goals, and current medications before deciding whether to prescribe.
  • Yes. Amble’s help-center FAQ describes managing an active treatment in the Patient Portal under Treatments, then Plan, with pause, turn-off, or cancellation options. It asks for a dashboard request or email at least 15 days before the next scheduled refill.
  • Amble’s Weight Loss FAQ lists New Mexico, Kansas, West Virginia, Louisiana, and Mississippi as requiring a short video or audio visit. It says most other patients can begin with an online health review.

What BMI and health criteria apply to Amble?

Amble’s public semaglutide safety information describes BMI 30 or greater, or 27 or greater with at least one weight-related condition. Its weight-loss FAQ says a licensed provider reviews health history, goals, and current medications before deciding whether to prescribe.

Those statements do not guarantee that every program, compound, or state is available to a particular applicant. Give the clinician an accurate history, including past GLP-1 treatment and any health changes.

Can I pause Amble without cancelling?

Yes. Amble’s help-center FAQ describes managing an active treatment in the Patient Portal under Treatments, then Plan, with pause, turn-off, or cancellation options. It asks for a dashboard request or email at least 15 days before the next scheduled refill.

Ask for confirmation of the affected shipment and payment. A shipping or subscription change is not advice to stop treatment; discuss the timing of a break and any restart with the clinician.

Which states require an Amble video or audio visit?

Amble’s Weight Loss FAQ lists New Mexico, Kansas, West Virginia, Louisiana, and Mississippi as requiring a short video or audio visit. It says most other patients can begin with an online health review.

This is Amble’s published operational list, not a complete survey of state law or a guarantee that no other live visit will be needed. Confirm the requirement for your present location, chosen treatment, and clinician before enrollment.

Sources: FAQs | Amble

What restrictions apply to Amble HSA/FSA payments?

Amble’s Weight Loss FAQ says HSA and FSA cards are accepted for plans lasting three months or longer and that itemized receipts are available for self-submission. Its broader help-center FAQ uses more general acceptance language, so confirm the restriction for your chosen plan.

Ask the benefits administrator whether the specific expense and documentation qualify. Amble can provide receipts and describes assistance with a medical-necessity letter, but those services do not guarantee reimbursement. Do not apply its separate Med Kit refill policies to GLP-1 treatment.

Read the complete answer to each question

Each question below has its own article, with a direct answer, practical context, and the documents behind it.

Sources:

Sources & research notes

Checked September 23, 2026. Provider pages document the provider’s own statements; they do not independently establish treatment safety or results. This is desk research, not a product test or clinical review.

  1. Home | AmbleProvider-published information · Checked September 23, 2026
  2. FAQs | AmbleProvider-published information · Checked September 23, 2026
  3. FREQUENTLY ASKED QUESTIONS (FAQ) | AMBLE HELP CENTERProvider-published information · Checked September 23, 2026

Read our methodology · Commercial disclosure · Request a correction